Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): Two novel markers of the psoriatic phenotype that respond differentially to topical steroid

Acta Dermato-Venereologica

Volumn 77, Issue 1, 1997, Pages 14-19

  Kuijpers, Astrid L A ^a   Bergers, Mieke ^a   Siegenthaler, Georges ^b   Zeeuwen, Patrick L J M ^a   Van De Kerkhof, Peter C M ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

corticosteroid; immunohistochemistry; proteinase inhibitor; psoriasis

Indexed keywords

CORTICOSTEROID; CRELO; FATTY ACID BINDING PROTEIN; HYDROCORTISONE BUTYRATE; MESSENGER RNA; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS; SKIN BIOPSY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; CARRIER PROTEINS; DOUBLE-BLIND METHOD; EPIDERMIS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; KERATINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; MYELIN P2 PROTEIN; NEOPLASM PROTEINS; PHENOTYPE; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; PSORIASIS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0031022677     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. de Mare S, van Erp PEJ, van de Kerkhof PCM. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections. J Invest Dermatol 1989; 92: 130-131.
2. Weiss RA, Eichner R, Sun TT. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56 kDalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984; 98: 1397-1406.
3. Kanitakis J, Zambruno G, Viac J, Thivolet J. Involucrin expression in keratinization disorders of the skin - a preliminary study. Br J Dermatol 1987; 117: 479-486.
4. Watt FM. Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 1983; 1: 100s-103s.
5. Michel S, Demarchez M. Localization and in vivo activity of epidermal transglutaminase. J Invest Dermatol 1988; 90: 472-474.
6. Wiedow O, Schröder J, Gregory H, Young JA, Christophers E. Elafin: an elastase specific inhibitor of human skin. Purification characterization and complete amino acid sequence. J Biol Chem 1990; 265: 14791-14795.
7. Wiedow O, Lüdemann J, Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun 1991; 174: 6-10.
8. Schalkwijk J, van Vlijmen IM, Alkemade JA, de Jongh GJ. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. J Invest Dermatol 1993; 100: 390-393.
9. Nonomura K, Yamanishi K, Yasuno H, Nara K, Hirose S. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis. J Invest Dermatol 1994; 103: 88-91.
10. Madsen P, Rasmussen HH, Leffers H, Honoré B, Celis JE. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol 1992; 99: 299-305.
11. Siegenthaler G, Hotz R, Chatellard-Gruaz D, Didierjean L, Hellman U, Saurat JH. Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochem J 1994; 302: 363-371.
12. Siegenthaler G, Hotz R, Chatellard-Gruaz D, Jaconi S, Saurat JH. Characterization and expression of a novel human fatty acid-binding protein: the epidermal type, (E-FABP). Biochem Biophys Res Commun 1993; 190: 482-487.
13. Corbett MF. The response of psoriasis to betamethasone valerate and clobetasol propionate. Br J Dermatol 1976; 94: 89-93.
14. Lavker RM, Schechter NM, Lazarus GS. Effects of topical corticosteroids on human dermis. Br J Dermatol 1986; 115: 101-107.
15. Bos JD, Krieg SR. Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans' cells and interdigitating cells. Acta Derm Venereol (Stockh) 1985; 65: 390-397.
16. de Jong EMGJ, de Zwart A, Wauben-Penris PJJ, Korstanje C, van de Kerkhof PCM. Effect of topical treatment with Budesonide (Preferid) on clinical scores, and on parameters for proliferation, keratinization and inflammation in psoriasis. J Dermatol Science 1995; 9: 185-194.
17. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
18. Molhuizen HOF, Alkemade HAC, Zeeuwen PLJM, de Jongh GJ, Wieringa B, Schalkwijk J. SKALP/Elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence and evidence for transglutaminase crosslinking. J Biol Chem 1993; 268: 12028-12032.
19. Rijzewijk JJ, van Erp PEJ, Bauer FW. Two binding sites for Ki-67 related to quiescent and cycling cells in human epidermis. Acta Derm Venereol (Stockh) 1989; 69: 512-515.
20. Chang A, de Jongh G, Mier PD, van de Kerkhof PCM. Enzymatic quantification of polymorphonuclear leukocytes in normal and psoriatic skin following standardized injury. Clin Exp Dermatol 1988; 13: 62-66.
21. van de Kerkhof PCM, Kuppens LHCM, van Vlijmen Y, Schalkwijk J. Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion. Br J Dermatol 1991; 124: 10-12.
22. Kuijpers ALA, Alkemade JAC, Schalkwijk J, van de Kerkhof PCM. Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis. Acta Derm Venereol (Stockh) 1995; 75: 110-113.
23. Veerkamp JH, Maatman RGHJ. Cytoplasmic fatty acid-binding proteins: their structure and genes. Prog Lipid Res 1995; 34: 17-52.
24. Rogers S. Measurement of plaque thickness and evaporative water loss in psoriasis with PUVA and dithranol treatment. Clin Exp Dermatol 1993; 18: 21-24.